Evaluation of the safety, immunogenicity and efficacy of a new live-attenuated lumpy skin disease vaccine in India

Lumpy skin disease (LSD) was reported for the first time in India in 2019 and since then, it has become endemic. Since a homologous (LSD-virus based) vaccine was not available in the country, goatpox virus (GPV)-based heterologous vaccine was authorized for mass immunization to induce protection aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Naveen, Barua, Sanjay, Kumar, Ram, Khandelwal, Nitin, Kumar, Amit, Verma, Assim, Singh, Lokender, Godara, Bhagraj, Chander, Yogesh, Kumar, Garvit, Riyesh, Thachamvally, Sharma, Deepak Kumar, Pathak, Anubha, Kumar, Sanjay, Dedar, Ramesh Kumar, Mehta, Vishal, Gaur, Mitesh, Bhardwaj, Bhupendra, Vyas, Vithilesh, Chaudhary, Sarjeet, Yadav, Vijaypal, Bhati, Adrish, Kaul, Rakesh, Bashir, Arif, Andrabi, Anjum, Yousuf, Raja Wasim, Koul, Abhimanyu, Kachhawaha, Subhash, Gurav, Amol, Gautam, Siddharth, Tiwari, Hari Audh, Munjal, Vijay Kumar, Gupta, Madhurendu K., Kumar, Rajender, Gulati, Baldev R., Misri, Jyoti, Kumar, Ashok, Mohanty, Ashok Kumar, Nandi, Sukdeb, Singh, Karam Pal, Pal, Yash, Dutt, Triveni, Tripathi, Bhupendra N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038050/
https://www.ncbi.nlm.nih.gov/pubmed/36919498
http://dx.doi.org/10.1080/21505594.2023.2190647

Ejemplares similares

Ejemplares similares